Baltimore, MD 20036-1984
United States
Johns Hopkins University
convalescent plasma, COVID-19, passive-antibody therapy, SARS-CoV-2
COVID-19 clinical trials, clinical trial management, convalescent covid plasma, single institutional review board (sIRB) oversight, Human Research Protection Official (HRPP) reviews, Informed Consent Form, return of trial results
COVID-19, SARS-CoV-2, convalescent plasma, neutralization antibody levels, fragment crystallizable antibody chain, safety, pharmacokinetics, randomized control trial, variants of concern